BiotechTube
Home/Syndeio Biosciences/John Donello, Ph.D.
JD

John Donello, Ph.D.

Chief Science Officer

Syndeio Biosciences

Therapeutic Areas

Neuropsychiatric DisordersCognitive DisordersMajor Depressive DisorderAlzheimer's Disease

Syndeio Biosciences Pipeline

DrugIndicationPhase
ZelquistinelMajor Depressive Disorder (MDD)Phase 2
ApimostinelMajor Depressive Disorder (Severe, Acute)Phase 2a

Leadership Team at Syndeio Biosciences

DS
Derek Small
Co-founder and Chief Executive Officer
MM
Michael McCully
President and Chief Operating Officer
AK
Aaron Koenig, M.D.
Chief Medical Officer
TC
Thomas C. Südhof, M.D.
Co-chair of Scientific Advisory Board
View full Syndeio Biosciences profile